(Date:7/18/2008)...f-the-art radiation technology impro...as, July 18 /PRNewswire/ -- Patients of Trinity Mo...logy-Tyler are among the first,in the nation to ha...that,provides faster and more accurate treatment f....newscom.com/cgi-bin/prnh/20061117/DAF023LOGO ),...
(Date:7/18/2008)...ing the benefits of resistance training in keeping...nwood, a postdoctoral research fellow with UQ and ...h investigated how people over the age of 65 respo...oking at was how simple resistance training can im...mance." Dr Henwood said. , "By building strengt...
(Date:7/18/2008)...ction to develop an integrated, comprehensive, nat... of losing its status as the global health care le...ion of Academic Health Centers (AAHC, www.aahcdc....h Macy, Jr. Foundation. , Out of Order, Out of T...rns that the nation is running out of time to ensu...
(Date:7/18/2008)...Call/ -- SyntheMed, Inc. (OTC,Bulletin Board: SYMD...nt,and commercialization of anti-adhesion, drug de...nced today the appointment of Ms. Corinne Mundin t...ional Market Development.,Ms. Mundin, who is based...ales management and market development experience ...
Breaking Medicine News(10 mins):Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 2Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 3Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 4Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 5Health News:The benefits of a little resistance for older adults 2Health News:New report warns current policies will not avert health workforce crisis 2Health News:SyntheMed Appoints Corinne Mundin as Director, International Market Development 2Health News:SyntheMed Appoints Corinne Mundin as Director, International Market Development 3...t out and it might save you a headache. A new stud...ger more than those without headaches. Of the 422 ... from headaches. Investigators measured //trait an...aily life), internalized anger, hostility, anxiety...
...of vitamin D. Each year, 200,000 women in the Unit...study shows one form of the vitamin may enhance th...Investigators compared tumor growth in mice treate... both radiation and EB 1089, a derivative of vitam...
...adly when tumor cells spread to the rest of the bo...t may be able to predict a tumor’s growth pattern,...chers from the University of Michigan Comprehensiv...d RKIP, which controls the ability of cancer cells...
... factors for age-related macular degeneration, a s...As the population ages, more and more people world...neration, or AMD. About 30 percent of people over ...most have mild or moderate forms of the disease, 6...
Other Medicine News:(Date:7/17/2008)...vival increase is observed in advanced non-small, ...njunction with standard ....5 months seen for patients with adenocar...ANTONIO, July 17 /- BioNumerik Pharma...t patients with adenocarcinoma (the most,frequentl...
(Date:7/17/2008)...lif., July 17 /- Anesiva,I...egun a Phase 2 clinical,trial of Adlea(TM), the co...g candidate for the management of acute pain in pa...volving rotator cuff repair., Adlea is currently ...total knee replacement surgeries and one in bunion...
(Date:7/16/2008)...ETY AND KAISER FAMILY FOUNDATION PARTNER TO,OFFER ...EE, MENLO PARK, Calif., and GENEVA, July 16 /PRNe...ty (IAS) and the Kaiser Family Foundation will,pro...onal AIDS Conference,(AIDS 2008) taking place in M...independent operating foundation based in Menlo Pa...
(Date:7/16/2008)...6 /- In the clinical phase I trial,AF...mer patients planned,for this trial. The trial aim... innovative Alzheimer,s vaccine (AFFITOPE AD01). I... at least once and have so far tolerated,the vacci... vaccinations,administered at monthly intervals an...
Breaking Medicine Technology:BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 2BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 3BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 4Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery 2Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery 3Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery 4Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews 2Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews 3Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews 4AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 2AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 3Is Your Dog a Canine stein or a Bonehead 3F 13596 1Is Your Dog a Canine stein or a Bonehead 3F 13596 2Is Your Dog a Canine stein or a Bonehead 3F 13596 3Genetic Test Predicts Response to Warfarin 13594 1Genetic Test Predicts Response to Warfarin 13594 2Genetic Test Predicts Response to Warfarin 13594 3Leukemia Therapy With Imatinib During Pregnancy May Cause Infant Abnormalities 1469 1Leukemia Therapy With Imatinib During Pregnancy May Cause Infant Abnormalities 1469 2Leukemia Therapy With Imatinib During Pregnancy May Cause Infant Abnormalities 1469 3Trubion Announces Presentations at Upcoming Investor Conferences 13591 1Trubion Announces Presentations at Upcoming Investor Conferences 13591 2Trubion Announces Presentations at Upcoming Investor Conferences 13591 3...--May 22, 2007 - Professor Ian,Meredith, M.D., Mon...ay presented positive nine-month results from the ...eeting in Barcelona, Spain,with data showing a lo...-defined stent thrombosis. The next-generation Med...g stent system with new,BioLinx(TM) polymer is des...
...tigation of Choroidal,Neovascularization (CNV) in ...FirstCall/ -- Lpath, Inc. ,the category leader in...rted compelling proof-of-concept data in a standar...ration (AMD). , The results were presented at the ...ision and Ophthalmology (ARVO) by Glenn,L. Stoller...
Other Medicine Technology:Medtronic Announces Positive Nine-Month Results for Endeavor,Resolute Next Generation Drug-Eluting Stent at EuroPCR 2Medtronic Announces Positive Nine-Month Results for Endeavor,Resolute Next Generation Drug-Eluting Stent at EuroPCR 3Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug,Candidate, Sphingomab 2Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug,Candidate, Sphingomab 3Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug,Candidate, Sphingomab 4Total Condylar Knee System has been researched, designed, tested and refined with the aid of sophisticated computer graphics and manufacturing technology. Its unique features provide implant stabilit
...best of digital mobile imaging just got better wit...re and instrumentation. Now using,your C-arm you...ualization and Navigation Technology, Minimize ...Decision Making, Provide a Platform for Future ...
...T.L.I.F. SG Instruments are the next evolution in ...fering comprehensive and functionally sound instru... variety of disc removal and disc preparation inst...ing TLIF procedure. Excellent design, a wide range...
...ips' Infinite Detector technology removes the cons...ltaneous slices it is expandable to as many slice...lication-specific integrated circuit (ASIC) chip, ...Mx8000 Dual is the premium configuration of the Mx...
Medicine Products: